Last reviewed · How we verify
SID530, Taxotere
Taxotere works by inhibiting microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the G2/M phase and apoptosis.
Taxotere works by inhibiting microtubule formation in the mitotic spindle, resulting in cell cycle arrest at the G2/M phase and apoptosis. Used for Adjuvant treatment of node-positive breast cancer, Locally advanced or metastatic breast cancer, Non-small cell lung cancer.
At a glance
| Generic name | SID530, Taxotere |
|---|---|
| Sponsor | SK Chemicals Co., Ltd. |
| Drug class | Taxane |
| Target | Microtubules |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 3 |
Mechanism of action
This action prevents cancer cells from dividing and leads to cell death. Taxotere is a chemotherapeutic agent that targets rapidly dividing cells, making it effective against various types of cancer.
Approved indications
- Adjuvant treatment of node-positive breast cancer
- Locally advanced or metastatic breast cancer
- Non-small cell lung cancer
- Prostate cancer
Common side effects
- Neutropenia
- Anemia
- Thrombocytopenia
- Fatigue
- Diarrhea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |